Current Clinical Trials Testing Combinations of Immunotherapy and Radiation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current Clinical Trials Testing Combinations of Immunotherapy and Radiation

Published:2015-01 Issue:1 Volume:25 Page:54-64
ISSN:1053-4296
Container-title:Seminars in Radiation Oncology
language:en
Short-container-title:Seminars in Radiation Oncology

Author:

Crittenden Marka,Kohrt Holbrook,Levy Ronald,Jones Jennifer,Camphausen Kevin,Dicker Adam,Demaria Sandra,Formenti Silvia

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Reference29 articles.

1. Combination of local irradiation with systemic application of anaerobic corynebacteria in therapy of a murinefibrosarcoma;Milas;Cancer Res,1975

2. Standard treatments induce antigen-specific immune responses in prostate cancer;Nesslinger;Clin Cancer Res,2007

3. Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer;Gulley;Prostate,2002

4. T-cell responses to survivin in cancer patients undergoing radiation therapy;Schaue;Clin Cancer Res,2008

5. Systemic effects of local radiotherapy;Formenti;Lancet Oncol,2009

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro-irradiated cancer vaccine enhances anti-tumor efficacy of radiotherapy and PD-L1 blockade in a syngeneic murine breast cancer model;Radiotherapy and Oncology;2024-11

2. TORCH-R trial protocol: hypofractionated radiotherapy combined with chemotherapy and toripalimab for locally recurrent rectal cancer: a prospective, single-arm, two-cohort, phase II trial;Frontiers in Oncology;2023-11-20

3. A review on lymphocyte radiosensitivity and its impact on radiotherapy;Frontiers in Oncology;2023-08-03

4. Overcoming Resistance to Immune Checkpoint Inhibitor Therapy Using Calreticulin-Inducing Nanoparticle;Pharmaceutics;2023-06-09

5. Irradiation plus myeloid-derived suppressor cell-targeted therapy for overcoming treatment resistance in immunologically cold urothelial carcinoma;British Journal of Cancer;2023-04-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3